ArticleCureus2026
Low-Grade Trichoblastic Carcinoma of the Scalp: A Rare Case Managed With Adjuvant Radiotherapy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Trichoblastic carcinoma (TBC) is a rare malignant adnexal tumor originating from follicular germinative cells. It can resemble basal cell carcinoma (BCC) both clinically and histologically, often leading to diagnostic and therapeutic challenges. We report a 44-year-old male patient who presented with a recurrent exophytic scalp lesion initially diagnosed as pilomatrixoma. Following wide local excision, histopathologic analysis revealed a low-grade TBC with narrow margins. Due to the close proximity of tumor cells to the surgical margins, the patient underwent adjuvant volumetric modulated arc therapy (VMAT) to a total dose of 50 Gy in 20 fractions. This case underscores the importance of accurate histopathologic differentiation between TBC and BCC. Surgical excision with adequate margins remains the treatment of choice, while adjuvant radiotherapy may be warranted in cases with narrow or positive margins to prevent recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.